Despite major financial struggles, some providers at a physician group in Washington, D.C. say their new — and much larger — parent is not offering the lifeline they want.
UHS deal exposes pitfalls of physician group acquisitions Read More »
La inteligencia artificial ha pasado en muy poco tiempo de ser una tecnología emergente a convertirse en una herramienta cotidiana en el entorno empresarial. Desde la generación de contenidos hasta el análisis de datos, cada vez son más los equipos que incorporan IA en su …
Adoptar la IA en la empresa: cómo hacerlo sin caos y de forma eficiente Read More »
A spokesperson said the layoffs were primarily in non-clinical or member facing roles.
UPMC to lay off 200 employees, cut 300 open positions Read More »
The staffing changes will focus resources on work that creates the highest impact for patients, according to Genentech. The number of employees affected is unknown, but longtime veteran Vishva Dixit is out.
Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years Read More »
Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be “completely different” than those being developed by MiniMed and Tandem Diabetes Care.
Why Insulet thinks its fully closed loop system will stand apart from rivals Read More »
The trust fund underpinning Medicare’s hospital benefit is set to run out of money one quarter earlier than previously expected as tax cuts in the GOP’s reconciliation legislation shrink Medicare’s revenue.
Medicare insolvency date creeps forward thanks to ‘Big Beautiful Bill,’ trustees find Read More »
Takeda eyes an FDA run for its investigational psoriasis pill after the drug elicited total skin clearance in more than 35% of patients at 16 weeks—more than 2.5 times that in controls taking Bristol Myers Squibb’s Sotyktu.
Takeda’s AI-designed pill bests BMS’ Sotyktu in head-to-head psoriasis trial Read More »
Biotechs are benefitting from the AI tech frenzy and inflation, but validated pipelines and careful planning are still key to the recent record-setting IPOs, experts say.
Sky-high Parabilis, Kailera IPOs spur optimism—but only for derisked biotechs Read More »
Un yacimiento paleontológico en el noroeste de China está plagado de restos de cientos de aves primitivas, incluidas algunas cuyos huesos rotos fueron triturados hasta convertirlos en bolitas. Estos extraños y fragmentados conjuntos de huesos de aves acumulados en este sitio han …
El misterioso depredador aéreo que cazaba a los primeros pájaros Read More »
It’s the latest Big Pharma deal for molecular glue technology and Novartis’ second with Orionis Biosciences, after first linking up in March 2020. The backloaded agreement will see Novartis pay $40 million upfront.
Novartis tightens bond with Orionis in up to $1.4B molecular glue deal Read More »
